BGR GOVERNMENT AFFAIRS

Lobbying for ALKERMES, INC. · Biopharmaceutical Company

Amended

The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Apr 21, 2025.

Filing 1st Quarter - Report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Feb 3, 2025

Income

$50,000.00

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Lobbyists on this filing 3

REMY LEIGH BRIM MASON

Previously held: Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren; Intern to Rep. Allyson Schwartz
JOHN STONE

Previously held: Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, Health Subcommittee; Intern, House E&C
RYAN LONG

Previously held: Senior Policy and Counsel, Speaker Kevin McCarthy; Senior Policy Advisor and Counsel, Minority Leader Kevin McCarthy; Deputy Staff Director and Staff Director, House Energy and Commerce Committee; LC, Rep Norwood; LA & LD, Rep Barton

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Health Issues

Provide strategic counsel and advocate on issues related to the biopharmaceutical industry generally, and Alkermes, Inc. specifically

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.